The transcription factor MEF2C is required for craniofacial development
about
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell linesThe MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10MEF2 transcription factors: developmental regulators and emerging cancer genesMolecular basis of cleft palates in miceNew perspectives on pharyngeal dorsoventral patterning in development and evolution of the vertebrate jawHypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathwaysIdentification and characterization of a Mef2 transcriptional activator in schistosome parasitesA p38 MAPK-MEF2C pathway regulates B-cell proliferationAltered mRNA Splicing, Chondrocyte Gene Expression and Abnormal Skeletal Development due to SF3B4 Mutations in Rodriguez Acrofacial DysostosisElectronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci.Robin sequence: from diagnosis to development of an effective management planRole of mef2ca in developmental buffering of the zebrafish larval hyoid dermal skeleton.Phenotypic subregions within the split-hand/foot malformation 1 locus.Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells.Combinatorial binding leads to diverse regulatory responses: Lmd is a tissue-specific modulator of Mef2 activity.Elucidating timing and function of endothelin-A receptor signaling during craniofacial development using neural crest cell-specific gene deletion and receptor antagonism.Understanding the basis of auriculocondylar syndrome: Insights from human, mouse and zebrafish genetic studies.Modes of developmental outgrowth and shaping of a craniofacial bone in zebrafish.Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35)Vertebrate paralogous MEF2 genes: origin, conservation, and evolutionDefective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish.Histone deacetylase-4 is required during early cranial neural crest development for generation of the zebrafish palatal skeletonHand2 function in second heart field progenitors is essential for cardiogenesis.Mef2c-F10N enhancer driven β-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cellsReceptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathwaysEndothelin signaling activates Mef2c expression in the neural crest through a MEF2C-dependent positive-feedback transcriptional pathway.MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathyMolecular signaling along the anterior-posterior axis of early palate development.Dlx genes pattern mammalian jaw primordium by regulating both lower jaw-specific and upper jaw-specific genetic programsMEF2C protects bone marrow B-lymphoid progenitors during stress haematopoiesis.A twist of insight - the role of Twist-family bHLH factors in development.Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations.Lack of oxygen in articular cartilage: consequences for chondrocyte biology.Myocyte enhancer factor 2C in hematopoiesis and leukemia.Mef2s are required for thick filament formation in nascent muscle fibres.An arterial-specific enhancer of the human endothelin converting enzyme 1 (ECE1) gene is synergistically activated by Sox17, FoxC2, and Etv2.Regulation of cardiac myocyte cell death and differentiation by myocardin.Transcriptional control of chondrocyte specification and differentiation.Cilia-dependent GLI processing in neural crest cells is required for tongue development.Transforming growth factor-β1 regulates expression of the matrix metalloproteinase 20 (Mmp20) gene through a mechanism involving the transcription factor, myocyte enhancer factor-2C, in ameloblast lineage cells.
P2860
2c71b30eb15ec54c05afffaa9817e8dad0db92546cf975c1b7e38f1284469209d979101340f1de8e7f5b416f585dfe52036d7a6450274b3f0b890e338e5847cfda48b53c99a80b50aac1b6f5a74a424a96d4a05101aa9be569fd6129e48db9cf659a004ab3fcb433eda408ab813fbbec15fed46e39135d98bff2f83937f7eb2aac7dca453f8b524f14752e34f59c649a9624dcf48aeba352d8ed62e94db1c119
P248
Q24303516-C5188FED-E33C-4730-8302-80E15C9FC97CQ24304297-604DFAC7-B357-47D8-9DDE-DA37454180EBQ26778515-9F33B012-EB15-44EB-BE54-0BD9737000A6Q26795762-2F451EF5-6AF7-4B0D-AEA5-A22C279E3E34Q26851854-98F33958-A6B0-419C-B9FE-08D2AB116539Q28260898-D5A13EAA-FF22-4926-8EC4-21F57A5E09F7Q28478689-D89C3CA7-9D95-4A2F-BE59-64078BE363E7Q28588781-745C249C-DE8F-44DE-9CB0-B3EC75079B27Q28595827-584073D7-DEB3-4A98-BE76-809FAA7D2E2AQ30303045-FBEE63B9-5152-4351-A6D1-055160F14DABQ30519488-80D82D3C-7531-49E5-AFB8-87BB8B7EC4CBQ30564456-7780798C-D979-48BF-B542-A69A0C916E31Q31042460-E3EB309E-DD0B-4C63-95F9-050239323C6FQ33426080-DF708074-E90C-440E-9900-1B6D69D32644Q33628780-74022FA8-A1E8-4179-BC65-9146210AE333Q33652466-DE091643-3126-4DCC-899C-2CC8A6C175A5Q33684451-AAB1A18D-4077-4A71-A349-0363C9F9841FQ33706110-50F00B28-FDB3-4D2C-A22F-516272B6F35CQ33761202-3D8C8C10-A178-40BC-9039-CC6DDC6DDD5CQ33843316-B090E66E-35C6-4DAB-AD3E-B0A909551EA1Q34204346-4B214C02-2980-460A-B909-AB6A4F952E60Q34296231-4E12ECD1-647F-4522-8534-B9E1F520C69AQ34574679-0BC4DDBA-074E-43FC-8F96-04C6350C2122Q35612239-3800594A-5CA6-4AB0-BB99-F660BA746090Q35669628-2E23FC89-8F90-42F3-A7BF-8DE80DDBFC75Q35999604-5CCA9DDB-4E74-48A6-97DA-B007B9E0014EQ36044670-20357849-9C04-495A-949F-8AEF254F5FCEQ36516812-0D6272C1-555F-4720-8C58-D3A200A6188DQ37020171-92FD2207-4DF6-4DA7-BE7C-37CE0130610AQ37181211-8D388AF8-A84E-4A90-85A3-5AB87A7F761EQ37332873-21963EEF-A1D3-4203-9B27-85AA703EE184Q37340867-90C06807-6AA6-45D8-84EB-79EA8C05FF03Q37729305-E51E03EA-A8BD-4E9B-9B16-580EA4D0F084Q38084093-DE2C49F0-C431-4085-87EC-7E3D1576CE96Q38301246-10D1893C-769B-4197-9E52-30B4108194EDQ38304524-F60FE31C-1858-4203-AC37-268950137509Q38669134-5DB605F8-3BB7-468F-BEB0-BFDB104297F9Q38803469-1B839AD3-A49F-4CD4-ABDE-CFB2293ECD0CQ38912342-304778A7-8C20-445C-BE3C-EC5BC85E2D35Q39027405-55E0DFA1-D4C1-4965-8BE9-5DEE9A2C35FF
P2860
The transcription factor MEF2C is required for craniofacial development
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The transcription factor MEF2C is required for craniofacial development
@ast
The transcription factor MEF2C is required for craniofacial development
@en
The transcription factor MEF2C is required for craniofacial development
@nl
type
label
The transcription factor MEF2C is required for craniofacial development
@ast
The transcription factor MEF2C is required for craniofacial development
@en
The transcription factor MEF2C is required for craniofacial development
@nl
prefLabel
The transcription factor MEF2C is required for craniofacial development
@ast
The transcription factor MEF2C is required for craniofacial development
@en
The transcription factor MEF2C is required for craniofacial development
@nl
P2093
P2860
P921
P3181
P1433
P1476
The transcription factor MEF2C is required for craniofacial development
@en
P2093
Courtney Brown
David J McCulley
John J Schwarz
Michael P Verzi
Pooja Agarwal
P2860
P304
P3181
P356
10.1016/J.DEVCEL.2007.03.007
P407
P577
2007-04-01T00:00:00Z